Oruka Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HQ1?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,640,8105.58%
Private Companies2,500,0008.5%
Hedge Funds2,936,9229.99%
Institutions4,168,03014.2%
General Public18,152,83361.7%

Dilution of Shares: HQ1 only recently listed within the past 12 months


Top Shareholders

Top 6 shareholders own 38.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
FMR LLC
4,167,599€112.0m0%0.01%
9.99%
Fairmount Funds Management LLC
2,936,922€78.9m0%6.54%
8.5%
Paragon Therapeutics, Inc.
2,500,000€67.2m0%no data
5.07%
Lawrence Klein
1,491,646€40.1m0%no data
0.51%
Cameron Turtle
149,164€4.0m0%no data
0.0015%
Dimensional Fund Advisors LP
431€11.6k0%no data